M&A Deal Summary |
|
|---|---|
| Date | 2007-04-25 |
| Target | CEVA Sante Animale |
| Sector | Life Science |
| Buyer(s) |
NiXEN Partners
Sagard IDIA Capital Investissement Merieux Equity Partners Ardian |
| Sellers(s) |
IK Partners
Intermediate Capital Group |
| Deal Type | Secondary Buyout |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 1998 |
| PE ASSETS | 600M EUR |
| Size | Middle-Market |
| Type | Sector Agnostic |
NiXEN is a French private equity group that targets investments in middle-market companies valued between €30 and €300 million. iXEN looks to invest €20 to €25 million of equity capital to support management buyouts/buy-ins, leveraged build-ups, owner buy-outs (OBOs), and public to private deals. The Firm is a 'hands-on' investment group and will consider opportunities in a variety of sectors, including manufacturing, consumer goods, specialist retailing, restaurants, and services. iXEN is supported by Natixis Private Equity and was formerly known as Natexis Industrie. The Firm was formed in 1998 and is based in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 13 of 31 |
| Sector (Life Science) | 1 of 2 |
| Type (Secondary Buyout) | 1 of 8 |
| Country (France) | 13 of 29 |
| Year (2007) | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-04-06 |
Saur
Issy-les-Moulineaux, France Saur is a drinking and wastewater management company focused on small/mid-sized cities across France. The company is also active internationally, particularly in Iberia, Saudi Arabia, and Poland. Saur was founded in 1933 and is based in Issy-les-Moulineaux, France. |
Sell | €2.3B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-05-31 |
Demos Group
Paris, France Demos Group is an education company focused on providing an actual person to person training and distance learning. The company has developed innovative and complementary training methods such as e-learning. Demos Group was formed in 1972 and is based in Paris. |
Sell | - |
| Category | Asset Manager |
|---|---|
| Founded | 2001 |
| PE ASSETS | 2.0B EUR |
| Size | Large |
| Type | Sector Agnostic |
Sagard is a multi-strategy alternative investment manager that invests across a variety of asset classes. These include private equity, public equity, private credit, royalties, and venture capital. Prospective transactions typically include buyouts or growth capital financings, where Sagard will consider either majority or minority positions. Sagard was formed in 2001 and is based in Montreal, Quebec.
| DEAL STATS | # |
|---|---|
| Overall | 16 of 40 |
| Sector (Life Science) | 1 of 1 |
| Type (Secondary Buyout) | 6 of 17 |
| Country (France) | 14 of 33 |
| Year (2007) | 5 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-03-01 |
Médi-Partenaires SAS
Paris, France Médi-Partenaires is the third largest group of private clinics in France, with 3% market share and 14 clinics focusing on obstetrics, surgery and medicine care. |
Sell | €600M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-09-20 |
FläktGroup
Herne, Germany FläktGroup is a provider of ventilation and air climate solutions for buildings as well as air movement solutions for industry and infrastructure applications. Fläkt has built up expertise in applications by delivering top BREEAM, LEED, DGNB or HQE solutions for major projects for: offices, hotels, hospitals, airports, and commercial construction projects including specialist applications like data-centers, pharmaceutical, marine, nuclear, oil and gas all over the world. FläktGroup was formed in 2002 and is based in Herne, Germany. |
Buy | €460M |
| Category | Corporate Investor |
|---|---|
| Founded | 1980 |
| PE ASSETS | 2.0B EUR |
| Size | Large |
| Type | Sector Focused |
IDIA Capital is a long-term agroindustry investor. Specific areas of interest include sectors related to the food industry, wine, agriculture production, and forestry. IDIA typically provides growth capital and can commit €2 to €50 million per transaction. IDIA is a unit of Crédit Agricole Group’s Private Equity & Finance Division. The Firm is based in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 16 of 96 |
| Sector (Life Science) | 2 of 5 |
| Type (Secondary Buyout) | 1 of 15 |
| Country (France) | 16 of 94 |
| Year (2007) | 4 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-01-01 |
Goûters Magiques
Bretagne, France Goûters Magiques is a food production company. Goûters Magiques is an industrial pastry generalist present in all segments of this market (filled and plain pancakes, individual filled cakes, pound cakes and other cakes to share, madeleines, brownies, muffins, fruit cakes, palm cakes, shortbread and other pastry specialities). Goûters Magiques is based in Bretagne, France. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-01-01 |
Avril Group
Paris, France Avril Group is an agro-industrial group, specialising in human nutrition, animal nutrition, renewable chemistry, and renewable energy. Avril Group was established in 1983 and is based in Paris, France. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 2009 |
| PE ASSETS | 1.3B EUR |
| Size | Large |
| Type | Sector Focused |
Mérieux Développement SAS is a venture and growth capital investment firm associated with family holding company Institut Mérieux. The Firm focuses on the health and nutrition sectors and will consider opportunities throughout North America and Europe. Mérieux Développement SAS was established in 2009 and is headquartered in Lyon, France.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 20 |
| Sector (Life Science) | 1 of 10 |
| Type (Secondary Buyout) | 1 of 6 |
| Country (France) | 1 of 12 |
| Year (2007) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-05-23 |
Lavorel Medicare
Lyon, France Lavorel Medicare is a service provider specialized in nursing care at home or in special care units. Lavorel Medicare was founded in 2012 and is based in Lyon, France. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 125.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Ardian is a mega-sized diversified investment group focused on opportunities worldwide. Ardian invests across and manages funds focused on small and mid-sized buyouts, growth capital financings, mezzanine, infrastructure, real estate, and co-investment opportunities. Ardian's small-buyouts group targets controlling interests in French, German, and Italian businesses valued up to €100 million. It's mid-sized buyout group seeks businesses valued up €1.5 billion and does not have any geographic limitations. The Infrastructure team looks for European opportunities and can commit up to €150 million per transaction. The Mezzanine group supports junior capital commitments of €5 to €80 million. In addition to direct investing, Ardian also manages various private equity fund-of-funds. Ardian was founded in 1996 and is based in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 83 of 418 |
| Sector (Life Science) | 3 of 16 |
| Type (Secondary Buyout) | 22 of 137 |
| Country (France) | 51 of 185 |
| Year (2007) | 10 of 28 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-04-19 |
Keolis SA
Paris, France Kéolis SA manages passenger transport networks for the account of local authorities and private contractors: buses, cars, subways, tramways, trolley buses, ferry networks, and maritime links. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-04-26 |
Alliance Boots
Zug, Switzerland Alliance Boots GmbH is an international pharmacy-led health and beauty group. Alliance Boots' pharmacy-led health and beauty retail businesses now operate more than 3,330 health and beauty retail stores in 11 countries and its pharmaceutical wholesale businesses supply medicines, other healthcare products and related services to more than 170,000 pharmacies, doctors, health centers and hospitals in 21 countries. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1989 |
| PE ASSETS | 14.0B EUR |
| Size | Mega |
| Type | Sector Agnostic |
Ik Investment Partners Ltd. (Formerly Industri Kapital) is a private equity firm that targets control investments in mid-sized manufacturing and service companies located in select European countries. IK focuses on growth businesses located in the Benelux region, as well as Denmark, Finland, France, Germany, Norway and Sweden. The firm looks to commit €50 to €150 million of equity capital per transaction and targets companies with 'a proven ability to generate significant cash flow' as well as an ability to 'sustain growth through various economic cycles'. IK Investment Partners was formerly known as Industry Kapital. IK Investment Partners was formed in 1989 and has offices in Hamburg, London, Paris, and Stockholm.
| DEAL STATS | # |
|---|---|
| Overall | 42 of 117 |
| Sector (Life Science) | 1 of 3 |
| Type (Secondary Buyout) | 8 of 49 |
| Country (France) | 4 of 26 |
| Year (2007) | 2 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-03-26 |
Myresjöhus AB
Vetlanda, Sweden Myresjöhus is a prefabricated house manufacturers in Sweden. |
Sell | kr1.9B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-05-08 |
Elektrokoppar AB
Helsingborg, Sweden Elektrokoppar is a winding wire and wire rod manufactures in Europe. The company supplies its products mainly to the electric industries. |
Sell | - |
| Category | Mezzanine Finance Firm |
|---|---|
| Founded | 1989 |
| PE ASSETS | 74.5B USD |
| Size | Mega |
| Type | Sector Agnostic |
Intermediate Capital Group (ICG) is a global mezzanine finance firm. IGC looks to provide junior capital to support a wide range of transactions, including buyouts, debt restructurings, and development financing. The Firm generally invests alongside financial sponsors and management teams in transactions valued from €250 million to €1 billion. ICG was formed in 1989 and is headquartered in London.
| DEAL STATS | # |
|---|---|
| Overall | 81 of 217 |
| Sector (Life Science) | 3 of 7 |
| Type (Secondary Buyout) | 29 of 83 |
| Country (France) | 25 of 58 |
| Year (2007) | 7 of 16 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-04-10 |
Ethypharm
SaintCloud, France Ethypharm is a Drug Delivery System (DDS) company. The company develops and manufactures medicinal products specialising in controlled release products. Drug Delivery Systems provide major benefits including improving the drug efficacy, enhancing patient compliance and comfort, extending the life cycle of existing drugs, and reducing the total cost of treatment. Ethypharm was founded in 1977 and is based in SaintCloud, France. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-04-26 |
Veda Group
Sydney, Australia Veda Group Ltd. is a provider of credit information and analysis in Australia and New Zealand. Veda delivers a suite of credit and other analytical products targeted to specific industry segments. |
Buy | $659M |
